New Evidence Emerges on Statin Side-Effects: Most Not Caused by Medication
A comprehensive review of evidence has found that nearly all side effects listed for statins, commonly prescribed to reduce heart attack risk, are not caused by the medication. According to a systematic review and meta-analysis published in The Lancet, only four out of 66 potential side effects - liver test changes, minor liver abnormalities, urine changes, and tissue swelling - have been supported by evidence.
This revelation comes as welcome news for millions of people who have been hesitant to take statins due to long-standing safety concerns. Statin labels now list dozens of possible side effects, ranging from memory problems and depression to sleep disturbances and nerve damage.
However, the study found that the risk of most listed side effects is minimal, with benefits far outweighing potential harms. Researchers examined 19 randomized controlled trials involving 124,000 people over an average follow-up period of four and a half years.
The lead author of the study, Christina Reith, emphasized that statins did not make commonly experienced events more frequent. For instance, the percentage of people suffering from memory loss per year was similar to those taking statin therapy as those not.
As a result, experts are calling for labels to be updated to better reflect the evidence and provide patients and doctors with more informed choices about statin use. Prof Sir Rory Collins stated that rapid revision of statin information is necessary to help patients and doctors make better-informed health decisions.
The study has been hailed as a much-needed counter to misinformation surrounding statins, which have been proven to protect against heart attacks and strokes. The British Heart Foundation, which part-funded the research, praised the findings, saying they should help prevent unnecessary deaths from cardiovascular disease.
A comprehensive review of evidence has found that nearly all side effects listed for statins, commonly prescribed to reduce heart attack risk, are not caused by the medication. According to a systematic review and meta-analysis published in The Lancet, only four out of 66 potential side effects - liver test changes, minor liver abnormalities, urine changes, and tissue swelling - have been supported by evidence.
This revelation comes as welcome news for millions of people who have been hesitant to take statins due to long-standing safety concerns. Statin labels now list dozens of possible side effects, ranging from memory problems and depression to sleep disturbances and nerve damage.
However, the study found that the risk of most listed side effects is minimal, with benefits far outweighing potential harms. Researchers examined 19 randomized controlled trials involving 124,000 people over an average follow-up period of four and a half years.
The lead author of the study, Christina Reith, emphasized that statins did not make commonly experienced events more frequent. For instance, the percentage of people suffering from memory loss per year was similar to those taking statin therapy as those not.
As a result, experts are calling for labels to be updated to better reflect the evidence and provide patients and doctors with more informed choices about statin use. Prof Sir Rory Collins stated that rapid revision of statin information is necessary to help patients and doctors make better-informed health decisions.
The study has been hailed as a much-needed counter to misinformation surrounding statins, which have been proven to protect against heart attacks and strokes. The British Heart Foundation, which part-funded the research, praised the findings, saying they should help prevent unnecessary deaths from cardiovascular disease.